WST - West Pharmaceutical Services, Inc.
| Previous Close | 145.78 |
| Open | 145.65 |
| Bid | 146.00 x 1100 |
| Ask | 146.11 x 900 |
| Day's Range | 145.02 - 147.15 |
| 52 Week Range | 91.75 - 147.15 |
| Volume | 210,939 |
| Avg. Volume | 284,940 |
| Market Cap | 10.762B |
| Beta (3Y Monthly) | 1.37 |
| PE Ratio (TTM) | 48.34 |
| EPS (TTM) | 3.02 |
| Earnings Date | Oct 23, 2019 - Oct 28, 2019 |
| Forward Dividend & Yield | 0.64 (0.47%) |
| Ex-Dividend Date | 2019-10-22 |
| 1y Target Est | 139.00 |
- Motley Fool
Forget the Inverted Yield Curve, These 3 Stocks Just Hit All-Time Highs
The charts for these three stocks show the kinds of curves that investors should really like -- trending upward.
- Zacks
MCK vs. WST: Which Stock Is the Better Value Option?
MCK vs. WST: Which Stock Is the Better Value Option?
- Simply Wall St.
Why West Pharmaceutical Services, Inc. (NYSE:WST) Could Be Worth Watching
Let's talk about the popular West Pharmaceutical Services, Inc. (NYSE:WST). The company's shares led the NYSE gainers...
- Zacks
Will West Pharmaceutical Continue to Surge Higher?
As of late, it has definitely been a great time to be an investor West Pharmaceutical.
- Zacks
West Pharmaceutical (WST) Hits 52-Week High, Can the Run Continue?
West Pharmaceutical (WST) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- Thomson Reuters StreetEvents
Edited Transcript of WST earnings conference call or presentation 25-Jul-19 1:00pm GMT
Q2 2019 West Pharmaceutical Services Inc Earnings Call
Motley FoolWest Pharmaceutical Services (WST) Q2 2019 Earnings Call Transcript
WST earnings call for the period ending June 30, 2019.
- Zacks
West Pharmaceutical Services (WST) Beats Q2 Earnings and Revenue Estimates
West Pharmaceutical (WST) delivered earnings and revenue surprises of 23.61% and 1.68%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
- PR Newswire
West Announces Second-Quarter 2019 Results and Announces an Increase to Fourth-Quarter 2019 Dividend
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , July 25, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter ...
- Zacks
Medical Products' Earnings Roster for Jul 25: SYK, BAX & More
Encouraging growth in the emerging markets is likely to be a bonus for the medical products space this earnings season.
- Simply Wall St.
These Fundamentals Make West Pharmaceutical Services, Inc. (NYSE:WST) Truly Worth Looking At
West Pharmaceutical Services, Inc. (NYSE:WST) is a stock with outstanding fundamental characteristics. When we build...
- Zacks
West Pharmaceutical Services (WST) Earnings Expected to Grow: Should You Buy?
West Pharmaceutical (WST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
HSIC vs. WST: Which Stock Should Value Investors Buy Now?
HSIC vs. WST: Which Stock Is the Better Value Option?
- PR Newswire
West to Host Second-Quarter 2019 Conference Call
EXTON, Pa., July 11, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter 2019 financial results before the market opens on Thursday, July 25, 2019, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. The conference ID is 6143018. An online archive of the broadcast will be available at the West website three hours after the live call and will be available through Thursday, August 1, 2019, by dialing 855-859-2056 (U.S.) or 404-537-3406 (International).
- Zacks
West Pharmaceutical (WST) Soars to 52-Week High, Time to Cash Out?
West Pharmaceutical (WST) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- Simply Wall St.
All You Need To Know About West Pharmaceutical Services, Inc.'s (NYSE:WST) Financial Health
Small-caps and large-caps are wildly popular among investors; however, mid-cap stocks, such as West Pharmaceutical...
- Insider Monkey
Here’s What Hedge Funds Think About West Pharmaceutical Services Inc. (WST)
Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients' money, and needless to say, they are painstakingly thorough when analyzing where to invest this money, as their own wealth also depends on it. Regardless of the various methods used by elite investors like David Tepper and David […]
- Markit
See what the IHS Markit Score report has to say about West Pharmaceutical Services Inc.
West Pharmaceutical Services Inc NYSE:WSTView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low * Economic output in this company's sector is contracting Bearish sentimentShort interest | PositiveShort interest is extremely low for WST with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting WST. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $926 million over the last one-month into ETFs that hold WST are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers’ Index (PMI) data, output in the Industrialsis falling. The rate of decline is very significant relative to the trend shown over the past year, and is accelerating. The rate of contraction may ease in the coming months, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- Simply Wall St.
Does West Pharmaceutical Services (NYSE:WST) Deserve A Spot On Your Watchlist?
Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of...
- PR Newswire
West NovaGuard® SA Pro Safety System Recognized for Excellence in Design and User Experience at the India Packaging Awards
EXTON, Pa., May 22, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, is pleased to announce that the NovaGuard® SA Pro safety system – a single-use accessory for prefilled ISO standard 1mL long staked-needle syringes – has won the India Packaging Awards for Excellence in Enhanced User Experience and Excellence in Packaging Design – Shapes and Structures. In addition, the company announced a new product line extension to its AccelTRA® component program, and showcased thought leadership with presentations at the UBM InnoPack Pharma Conference in Mumbai. The prestigious India Packaging Awards, presented on May 21, 2019 during a ceremony held at the Sahara Star Hotel, are an initiative by UBM to honor the best innovations in the Pharma Packaging space.
- GuruFocus.com
Insulet and West Pharma Proven Winners in Growing Wearable Devices Market
With rapid growth projected for the market for wearable drug delivery devices, investors would be wise to consider some of the key players in the business. Two standouts are Boston-area-based Insulet (PODD) and West Pharmaceutical Services (WST), which is headquartered in Exton, Pennsylvania. Warning! GuruFocus has detected 4 Warning Signs with PODD.
- Simply Wall St.
The West Pharmaceutical Services (NYSE:WST) Share Price Has Gained 186%, So Why Not Pay It Some Attention?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift...
- Zacks
ABC vs. WST: Which Stock Is the Better Value Option?
ABC vs. WST: Which Stock Is the Better Value Option?
- PR Newswire
West Announces Third-Quarter Dividend and Participation in Upcoming Investor Conferences
EXTON, Pa., May 8, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a third-quarter 2019 dividend of $0.15 per share. The Company also announced that management will present an overview of the business at three investor conferences in May and June. A live audio webcast of the presentations and a copy of the presentation materials will be accessible from the Company's website at www.westpharma.com/en/investors.
